Axon Enterprise, Inc. AXON
Verdict: Sell. Fair value $368 against a price of $599 on 5 Jan 2026, 39% below the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: OCF/Net Income ratio compressed from 1.60 in 2022 to 1.08 in 2024, suggesting potential working.... Financial data provided is for FY2024, while market data suggests late 2025 context (Next Earnings....
Main risks
- Significant deterioration in Operating Cash Flow (TTM $0.24B vs 2024 Annual $0.41B) despite revenue growth
- Extreme valuation multiples (P/S ~18x) pricing in perfection
- Large divergence between Net Income ($0.38B) and Free Cash Flow ($0.15B) suggests lower earnings quality
- OCF/Net Income ratio compressed from 1.60 in 2022 to 1.08 in 2024, suggesting potential working...
- Valuation prices in optimistic scenario (limited margin for error)
- OCF/Net Income ratio compressed from 1.60 in 2022 to 1.08 in 2024, suggesting potential working capital drag or reduced non-cash add-backs.